Comparison between Self-Completed and Interviewer-Administered 24-Hour Dietary Recalls in Cancer Survivors: Sampling Bias and Differential Reporting.
Rana E ConwayGabriella HeuchanHelen CrokerSara EsserVictoria IrelandPhillippa LallyRebecca J BeekenAbigail FisherPublished in: Nutrients (2022)
Self-completed 24 h dietary recalls (24-HRs) are increasingly used for research and national dietary surveillance. It is unclear how difficulties with self-completion affect response rates and sample characteristics. This study identified factors associated with being unable to self-complete an online 24-HR but willing to do so with an interviewer. Baseline 24-HRs from the ASCOT Trial were analysed ( n = 1224). Adults who had been diagnosed with cancer in the past seven years and completed treatment, were invited to self-complete 24-HRs online using myfood24 ® . Non-completers were offered an interviewer-administered 24-HR. One third of participants willing to provide dietary data, were unable to self-complete a 24-HR. This was associated with being older, non-white and not educated to degree level. Compared to interviewer-administered 24-HRs, self-completed 24-HRs included 25% fewer items and reported lower intakes of energy, fat, saturated fat and sugar. This study highlights how collection of dietary data via online self-completed 24-HRs, without the provision of an alternative method, contributes to sampling bias. As dietary surveys are used for service and policy planning it is essential to widen inclusion. Optimisation of 24-HR tools might increase usability but interviewer-administered 24-HRs may be the only suitable option for some individuals.
Keyphrases
- healthcare
- electronic health record
- public health
- adipose tissue
- health information
- clinical trial
- social media
- young adults
- emergency department
- blood pressure
- big data
- palliative care
- physical activity
- fatty acid
- papillary thyroid
- cross sectional
- phase ii
- deep learning
- data analysis
- adverse drug
- phase iii
- squamous cell
- combination therapy
- open label